Vimarsana
Biggest News Aggregation in the World

Page 7 - Evoke Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evoke Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evoke Pharma Today - Breaking & Trending Today

Evoke Pharma (NASDAQ:EVOK) Share Price Crosses Below 200 Day Moving Average of $1.49 - Vimarsana News

Evoke Pharma (NASDAQ:EVOK) Share Price Crosses Below 200 Day Moving Average of $1.49

Evoke Pharma, Inc. (NASDAQ:EVOK – Get Free Report) crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $1.49 and traded as low as $1.15. Evoke Pharma shares last traded at $1.28, with a volume of 26,677 shares traded. Wall Street Analysts […]

Evoke Pharma & EVERSANA Unveil Cost Savings Real-World Data - Vimarsana News

Evoke Pharma & EVERSANA Unveil Cost Savings Real-World Data

Reduction in emergency department visits, hospitalizations and office visits caused diabetic gastroparesis patients and insurers to save over $15,000 for...

Evoke Pharma (NASDAQ:EVOK) Research Coverage Started at StockNews.com - Vimarsana News

Evoke Pharma (NASDAQ:EVOK) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Evoke Pharma (NASDAQ:EVOK – Free Report) in a report issued on Wednesday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Evoke Pharma Trading Down 3.5 % NASDAQ EVOK opened at $1.11 on Wednesday. The stock’s 50-day simple moving average is $1.19 and its two-hundred […]

Source: wkrb13.com
Reviewing Acura Pharmaceuticals (OTCMKTS:ACUR) & Evoke Pharma (NASDAQ:EVOK) - Vimarsana News

Reviewing Acura Pharmaceuticals (OTCMKTS:ACUR) & Evoke Pharma (NASDAQ:EVOK)

Evoke Pharma (NASDAQ:EVOK – Get Free Report) and Acura Pharmaceuticals (OTCMKTS:ACUR – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, earnings, analyst recommendations, institutional ownership, profitability and risk. Analyst Recommendations This is a breakdown of […]

Evoke Pharma (NASDAQ:EVOK) Research Coverage Started at StockNews.com - Vimarsana News

Evoke Pharma (NASDAQ:EVOK) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Evoke Pharma (NASDAQ:EVOK – Free Report) in a report issued on Tuesday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Evoke Pharma Stock Performance Shares of EVOK stock opened at $1.28 on Tuesday. The company’s fifty day moving average price is $1.20 and its 200-day […]